BIO

vaccine

What's the ROI on a COVID vaccine? We have no idea, says Pfizer

As Pfizer rushes to develop an mRNA vaccine against COVID-19, the company is trying to balance ROI demands from investors with public health needs.

Arlene Weintraub Jun 11, 2020 10:40am

GlaxoSmithKline GSK House in Brentford UK

With rep pay tweaks, GSK isn't going back to its old ways: exec

Jun 14, 2019 9:26am

Servier

France's Servier builds out its vision for U.S. future

Jun 7, 2019 11:15am